MENU

IRD Opus Genetics Inc Forecast, Technical & Fundamental Analysis

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders... Show more

IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GDSTX32.90N/A
N/A
Goldman Sachs Small Cap Eq Insghts Inv
PRNHX59.56N/A
N/A
T. Rowe Price New Horizons
MSGCX11.19N/A
N/A
Meridian Small Cap Growth C
PLIBX40.83N/A
N/A
Plumb Balanced Institutional
RIVIX21.03-0.19
-0.90%
American Funds Intl Vntg R-3

IRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with ROIV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
-2.81%
ROIV - IRD
36%
Loosely correlated
-4.06%
IMUX - IRD
36%
Loosely correlated
-0.88%
ARRY - IRD
35%
Loosely correlated
-3.92%
MGX - IRD
32%
Poorly correlated
+3.94%
AVBP - IRD
32%
Poorly correlated
-0.15%
More
Opus Genetics (IRD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com